Recent evidence suggests that standard chemotherapeutic drugs induce RIPK3-dependent necroptosis in multiple cancer cell lines [24] and that chemotherapeutic drug-induced necroptosis rather than apoptosis reduces tumor growth in vivo [46]. The gene discussed is RIPK3; the disease is neoplasm.